| pubmed-article:19950813 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C0008311 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C0031727 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C0334094 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C1332721 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C0205191 | lld:lifeskim |
| pubmed-article:19950813 | lifeskim:mentions | umls-concept:C2930586 | lld:lifeskim |
| pubmed-article:19950813 | pubmed:issue | 94-95 | lld:pubmed |
| pubmed-article:19950813 | pubmed:dateCreated | 2009-12-2 | lld:pubmed |
| pubmed-article:19950813 | pubmed:abstractText | High stone recurrence and biliary restenosis rates in hepatolithiasis patients have been confirmed to be closely related to postoperatively-remnant chronic proliferative cholangitis (CPC), but effective management strategies have not yet been developed. Since CPC is a type of hyperplastic disease, this study was designed to investigate inhibitory effectiveness of cdc2 k ShRNA on hyperplastic behavior and lithogenic potentiality of CPC. | lld:pubmed |
| pubmed-article:19950813 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19950813 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19950813 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19950813 | pubmed:issn | 0172-6390 | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:OrrE CEC | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:ChengJing-Qiu... | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:ZhouYongY | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:ChengNan-Shen... | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:LiQuan-ShengQ... | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:LiFu-YuFY | lld:pubmed |
| pubmed-article:19950813 | pubmed:author | pubmed-author:JiangLi-Sheng... | lld:pubmed |
| pubmed-article:19950813 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:19950813 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:19950813 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19950813 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19950813 | pubmed:pagination | 1477-82 | lld:pubmed |
| pubmed-article:19950813 | pubmed:dateRevised | 2011-1-11 | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:meshHeading | pubmed-meshheading:19950813... | lld:pubmed |
| pubmed-article:19950813 | pubmed:articleTitle | Practical value of applying cdc2 kinase shRNA to chronic proliferative cholangitis in treatment of hepatolithiasis. | lld:pubmed |
| pubmed-article:19950813 | pubmed:affiliation | Department of Hepatobiliary Surgery, West China Hospital of Sichuan University, Chengdu, China. | lld:pubmed |
| pubmed-article:19950813 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19950813 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
